Neurocrine Biosciences Aktie
141,75
EUR
-0,05
EUR
-0,04
%
161,40
USD
-0,19
USD
-0,12
%
Neurocrine Biosciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Neurocrine Biosciences Aktie Analyse
| 14.12.07 | Neurocrine Biosciences underperform | Bear Stearns Companies Inc. | |
| 14.12.07 | Neurocrine Biosciences sell | Piper Jaffray & Co. | |
| 14.12.07 | Neurocrine Biosciences underperform | Jefferies & Company Inc. | |
| 29.06.06 | Neurocrine Biosciences reduce | UBS | |
| 23.06.06 | Neurocrine Biosciences underweight | Morgan Stanley | |
| 23.06.06 | Neurocrine Biosciences sell | Citigroup | |
| 16.06.06 | Neurocrine Biosciences underperform | Leerink Swann | |
| 16.06.06 | Neurocrine Biosciences underperform | Robert W. Baird | |
|
Werbung
|
|||
| 16.06.06 | Neurocrine Biosciences Underperform | Leerink Swann | |
| 18.05.06 | Neurocrine Biosciences underperform | Jefferies & Co | |
Werbung
Werbung